Bajaj Healthcare Limited announced the outcome of its Board Meeting held on January 16, 2026. The Board approved the un-audited financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Report from its statutory auditors, Walker Chandiok & Co. LLP. Furthermore, the Board approved the re-appointment of key managerial personnel for a period of three years, subject to shareholder approval. Mr. Sajankumar Rameshwarlal Bajaj will continue as Chairman & Managing Director from April 1, 2026, to March 31, 2029. Mr. Anil Champalal Jain has been re-appointed as Managing Director for the same period. Ms. Namrata Sajankumar Bajaj will continue as Whole-Time Director from April 1, 2026, to March 31, 2029, and Mr. Pakshal Anil Jain will continue as Whole-Time Director from June 30, 2026, to June 29, 2029. The Board also approved the notice for a postal ballot for seeking shareholder approval for these re-appointments. The company confirmed that the re-appointed directors are not debarred from holding office by any regulatory authority. The Board meeting commenced at 4:15 p.m. and concluded at 5:00 p.m.
